Background: Self-reported short or long sleep duration has been associated with adverse cardiometabolic health outcomes in laboratory and epidemiologic studies, but interpretation of such data has been limited by methodologic issues. Methods: Adult respondents of the 2007-2008 US National Health and Nutrition Examination Survey (NHANES) were examined in a cross-sectional analysis (N = 5649). Self-reported sleep duration was categorized as very short (<5 h), short (5-6 h), normal (7-8 h), or long (P9 h). Obesity, diabetes mellitus (DM), hypertension, and hyperlipidemia were objectively assessed by self-reported history. Statistical analyses included univariate comparisons across sleep duration categories for all variables. Binary logistic regression analyses and cardiometabolic factor as outcome, with sleep duration category as predictor, were assessed with and without covariates. Observed relationships were further assessed for dependence on race/ethnicity. Results: In adjusted analyses, very short sleep was associated with self-reported hypertension (odds ratio [OR], 2.02, [95% confidence interval {CI},1.45-2.81]; P < 0.0001), self-reported hyperlipidemia (OR, 1.96 [95% CI, 1.43-2.69]; P < 0.0001), objective hyperlipidemia (OR, 1.41 [95% CI, 1.04-1.91]; P = 0.03), selfreported DM (OR, 1.76 [95% CI, 1.13-2.74]; P = 0.01), and objective obesity (OR, 1.53 [95% CI, 1.03-1.43]; P = 0.005). Regarding short sleep (5-6 h), in adjusted analyses, elevated risk was seen for selfreported hypertension (OR, 1.22 [95% CI, 1.02-1.45]; P = 0.03) self-reported obesity (OR, 1.21 [95% CI, 1.03-1.43]; P = 0.02), and objective obesity (OR, 1.17 [95% CI, 1.00-1.38]; P < 0.05). Regarding long sleep (P9 h), no elevated risk was found for any outcomes. Interactions with race/ethnicity were significant for all outcomes; race/ethnicity differences in patterns of risk varied by outcome studied. In particular, the relationship between very short sleep and obesity was strongest among blacks and the relationship between short sleep and hypertension is strongest among non-Hispanic whites, blacks, and non-Mexican Hispanics/Latinos. Conclusions: Short sleep duration is associated with self-reported and objectively determined adverse cardiometabolic outcomes, even after adjustment for many covariates. Also, these patterns of risk depend on race/ethnicity.
Introduction
Both self-reported short and long sleep duration have been associated with elevated risk for obesity in children and adults [1] [2] [3] [4] [5] [6] [7] , as well as cardiovascular disease [8] [9] [10] , diabetes mellitus (DM) [4, 11, 12] , hypertension [2, 13, 14] , and other negative health outcomes [2, [15] [16] [17] (i.e., all-cause mortality) [16, [18] [19] [20] [21] . These findings have been summarized in reviews utilizing both quantitative [8, 19, 20, 22, 23] and narrative [3, 16, 17, [24] [25] [26] [27] [28] approaches.
Small-scale experimental studies have shown that short-term sleep deprivation may lead to metabolic dysregulation [29] [30] [31] [32] [33] [34] , elevated inflammation [35, 36] , and elevated blood pressure (BP) [37] . Whether or not these findings translate to associations with habitual sleep in general population samples remains unclear. Epidemiologic studies, while typically more generalizable, have methodologic limitations such as inconsistent definitions of short and long sleep duration categories, inconsistent assessments (e.g., differently worded survey items) [17] , variable measurement techniques (e.g., diaries, actigraphy, polysomnography) [38] , and occasionally non-representative samples (i.e., large scale samples that are restricted to defined regions [39] , older [40, 41] or younger [6, 13, 42] adults, or a single gender [40, [43] [44] [45] or race/ethnicity [46] ). Further, and most importantly, assessments of disease or disease risk often are confined to subjective questions (e.g., ''Have you ever been diagnosed with. . .''), rather than objective determinations based on medication use and physiologic measurements (e.g., BP, serum cholesterol, fasting glucose levels). It is plausible that the use of such measures, in combination with measures of self-rated sleep duration, may allow for a more precise determination if laboratory findings generalize to the population at large.
In our study, associations between sleep duration and cardiometabolic risk factors were evaluated using data from the 2007-2008 National Health and Nutrition Examination Survey (NHANES). Specifically, short and long sleep duration were assessed for their association with self-reported and objective measures of hypertension, hyperlipidemia, DM, or obesity while utilizing (1) a census-weighted nationally representative sample, (2) previously established categories of self-reported sleep duration [2, 17, 47, 48] , (3) simultaneous assessment of risk domains, and (4) statistical controls for differential effects of race/ethnicity. It was hypothesized that short and long sleep duration, relative to normal sleep duration, would be associated with increased cardiometabolic risk, even after accounting for self-reported/objective differences in risk assessment and confounding factors. The primary goal of these analyses is to replicate and extend previous findings in a gold-standard representative sample. Specifically, we attempted to clarify if the relationships differed depending on how outcomes were determined; we also attempted to demonstrate that these relationships were further complicated by race/ ethnicity differences, which only rarely have been examined [49, 50] .
Methods

Data source
Participants included respondents to the 2007-2008 NHANES, a national survey conducted by the Centers for Disease Control and Prevention to assess the health and nutritional characteristics of children and adults [51] [52] [53] . The NHANES methodology, surveys, manuals, and procedures are available on the NHANES website (http://www.cdc.gov/nchs/nhanes). Participants responded to questionnaires assessing demographic, socioeconomic, health, and other domains during face-to-face in-home interviews. To supplement self-report data, physical examination data were gathered in mobile medical facilities. Additional laboratory tests including blood samples also were collected on site. Blacks, Hispanics, and adults over the age of 60 years were over sampled to increase the power to detect differences in these groups. The NHANES is designed to ensure generalizability to the entire population across all ages. Given the complexity of the survey design, coupled with variable probabilities of selection, the data used in the following analyses also were weighted to control for representativeness, by following the procedures outlined in the current NHANES Analytic and Reporting Guidelines [52] . Presently data on adults ages 18 years and older (mean age, 49.3 years; standard deviation, 18.6 years) with complete data on our variables of interest were analyzed. All respondents provided informed consent. Consent forms are available online (http://www.cdc.gov/nchs/nhanes/ nhanes2007-2008/current_nhanes_07_08.htm).
Measures
Sleep duration
Sleep duration was assessed with the survey item, ''How much sleep do you usually get at night on weekdays or workdays?'' Responses were coded in whole numbers. Based on previous studies [2, 47, 54] , responses were categorized as very short (<5 h), short (5-6 h), normal (7-8 h), or long (P9 h). These categories were based on existing literature examining cardiovascular and metabolic consequences of habitual sleep duration and experimental sleep restriction.
Hypertension
Self-reported hypertension was assessed with the survey item, ''Have you ever been told by a doctor or other health professional that you had hypertension, also called high BP?'' Objective hypertension was assessed as any one of the following: (1) endorsement of the question, ''Because of high BP/hypertension, have you ever been told to take prescribed medicine?'' (2) a report of a current antihypertensive medication during a medical history evaluation, or (3) measured BP during the medical examination of >140/ 90 mmHg. Procedures for BP measures, including equipment lists, equipment maintenance standards, test administration procedures, and interpretation guidelines, are publicly available in the NHANES Physician Examination Procedures Manual [55] . Briefly, measurements are obtained from rested, seated participants, with three measurements at least 30 s apart, and a fourth reading if any of the first three were questionable. The values reported are the mean of the available non questionable recordings.
Hyperlipidemia
Self-reported hyperlipidemia was assessed with the survey item, ''Have you ever been told by a doctor or other health professional that your blood cholesterol level was high?'' Objective hyperlipidemia was assessed as any of the following: (1) endorsement of the question, ''To lower your blood cholesterol, have you ever been told by a doctor or other health professional to take prescribed medicine?'' (2) a report of a current statin or other lipidlowering medication during a medical history evaluation, or (3) measured serum cholesterol during the medical examination of >240 mg/dL (reference range, <200 mg/dL).
DM
Self-reported DM was assessed with the survey item, ''Other than during pregnancy, have you ever been told by a doctor or other health professional that you have DM or sugar DM?'' Objective DM was assessed as any of the following: (1) endorsement of the question, ''Are you now taking insulin?'' or ''Are you now taking diabetic pills to lower your blood sugar?'' (2) a report of a current hypoglycemic or other diabetic medication during a medical history evaluation, or (3) measured fasting glucose of >125 mg/dL (reference range, 70-110 mg/dL).
Obesity
Body mass index (BMI) was computed using both self-reported height and weight and objectively measured height and weight recorded during a physical examination. A BMI P30 kg/m 2 was considered to be obese. [56] [57] [58] [59] ; socioeconomic factors suspected to affect sleep and health outcomes [1, 56] , which included education level (less than high school, high school, some college, college graduate), access to health insurance (none, public, or private), home ownership (yes or no), and food security (normal borderline, low, or very low, were measured using standard US Department of Agriculture criteria [60] ). Other health risk factors included current smoking (yes or no) and regular caffeine use (yes or no). Other covariates were considered, including income and alcohol, among others. However, non response to these items (e.g., >800 missing responses to alcohol items) suggested that their inclusion as a covariate would significantly impinge on inferences. Other potential covariates also were not included. Because a nearly unlimited number of factors could potentially be associated with any of the cardiometabolic risk factors assessed in our study, it is unlikely that any model could fully account for these factors. Further, adding many covariates introduces the problem of compounded measurement error, especially for self-reported measures. In addition, many of those variables that may affect cardiometabolic risk factors could at least partially be a consequence of changes in sleep, including these as covariates; then examining the unique variance explained by sleep leads to biased statistical estimates. Therefore, our study adopts an approach of inclusion for the sake of generalizability rather than exclusion based on potential confounding conditions. This inclusion also allows for maximal comparison across studies, though interpretations of these data need to be made in the context that population surveys may include individuals with other conditions.
Summary variables
Cardiometabolic outcomes, including self-reported and objective hypertension, hyperlipidemia, DM and obesity, were operationalized as dichotomous variables. Sleep duration was operationalized as a categorical variable, with normal sleep (7-8 h/night) as a reference. All summary variables were inspected with regard to distribution and central tendency.
Analytic Strategy
Univariate comparisons across sleep duration categories for all variables were evaluated using v 2 tests. For the primary analyses, binary logistic regression analyses with cardiometabolic outcome and sleep duration category as predictor, were assessed with and without covariates. To assess if the observed relationships depended on race/ethnicity based on prior sleep and cardiovascular literature, terms were evaluated for sleep duration by race/ethnicity interactions in a model with all other covariates. If an interaction term was significant, analyses stratified by race/ethnicity were explored. Note: the number of covariates entered into the analyses was limited to mitigate reporting bias and to avoid the creation of models that were over-controlled. Two-tailed P values of <0.05 were used as the threshold for the determination of significance. All statistical calculations were performed using STATA/SE version 12 (STATA Corp, College Station TX).
Results
Characteristics of the sample
The analyses included data from 5649 respondents, whose characteristics are summarized in Table 1 . Of 6220 participants who responded to the sleep duration item, 571 were excluded because they were missing some or all of the following: at least one of the sociodemographic or socioeconomic covariate (N = 94), smoking (N = 154), hypertension (N = 6), DM (N = 6), and objective height and weight (N = 311). The v 2 tests show group differences according to demographic, socioeconomic, and health variables, supporting their inclusion as covariates. In addition, overall group differences were seen for self-reported and objective hypertension, hyperlipidemia, DM, and obesity.
Regression analyses
Results of binary logistic regression analyses using normal sleep (7-8 h) as the reference category can be seen in Table 2 . Unadjusted analyses revealed that very short sleep (<5 h) was associated with elevated risk for all outcomes, relative to normal sleep. After adjustment for covariates, significant relationships remained for self-reported hypertension, self-reported and objective hyperlipidemia, self-reported DM, and objective obesity. All other variables were attenuated to trends (P < 0.10). In unadjusted analyses, short sleep (5-6 h) was associated with elevated risk for self-reported and objective hypertension and self-reported and objective obesity. In adjusted analyses, all relationships except objective hypertension persisted. Regarding long sleep (P9 h), elevated risk was found for objective DM, in unadjusted analyses only.
To ensure that the observed relationships were not confounded by obesity, adjusted analyses were recomputed including BMI as a covariate. All relationships remained significant except for elevated hyperlipidemia in very short sleep (P = 0.052).
Race/ethnicity interactions
In adjusted models, significant interactions between sleep duration category and race/ethnicity were found for self-reported hypertension (P < 0.0001), objective hypertension (P < 0.0001), self-reported hyperlipidemia (P = 0.007), objective hyperlipidemia (P< 0.005), self-reported DM (P< 0.001), objective DM (P< 0.0003), self-reported obesity (P< 0.0001), and objective obesity (P< 0.0001). Thus adjusted analyses were stratified for these outcomes. With the caveat that restricted samples reduce statistical power, especially in the less populous groups, individual findings were explored using stratified analyses. Results of these analyses are found in Supplementary Fig. 1 and Supplementary Table 1 . Overall, for non-Hispanic white respondents, elevated risk was found for self-reported hypertension, self-reported hyperlipidemia, objective hyperlipidemia, and self-reported DM among very short sleepers; no outcomes among short sleepers; and objective hyperlipidemia among long sleepers. For black respondents, elevated risk for self-reported hypertension, self-reported obesity, and objective obesity were found for very short sleep. For MexicanAmericans, elevated risk for self-reported hypertension and selfreported obesity were found for short sleep and decreased self-reported hyperlipidemia was seen in long sleep. For other Hispanic/Latino respondents, elevated risk for self-reported hypertension was found for very short sleep and objective DM for short sleep. Among Asian/other respondents, elevated risk for self-reported and objective hyperlipidemia were found for very short sleep.
Discussion
Our study evaluated the associations between sleep duration and self-reported/objective cardiometabolic risk factors. The hypotheses that both short and long sleep would be associated with self-reported and objective hypertension, hyperlipidemia, DM, and obesity, were partially confirmed. Very short sleep (<5 h) was most strongly associated with the widest range of adverse outcomes, followed by short sleep (5-6 h). This finding is consistent with previous studies, which generally have found habitual sleep in this range to be associated with the largest risk. Altman et al. [2] found that sleep duration <5 h was associated with elevated risk for self-reported obesity, hypertension, hypercholesterolemia, heart attack, and stroke, whereas average nightly sleep duration of 5-6 h was associated with a greatly attenuated risk which frequently was nonsignificant, relative to 7 h. Other studies have identified a similar pattern, suggesting the shortest sleepers are at the greatest risk while those in the more normative short sleep range (6 h) generally are not at increased risk [2, 54] . Although it is unclear why results across studies reflecting 6-h sleepers are inconsistent in this regard, it may reflect a measurement issue (e.g., variability in sleep duration assessments) or characteristics of those in this group (e.g., more heterogeneity regarding resilience to sleep loss). Long sleep was not found to be associated with risk factors, especially after adjustment. Although several studies have identified risks associated with long sleep duration [61] , our study did not detect any such risks. Previous literature on long sleep is highly variable, perhaps because self-reported long sleep is frequently limited to the unemployed, ill, or retired [44, 62] and may reflect long time in bed rather than long time asleep.
Sleep duration and hypertension
Our findings regarding hypertension are consistent with previous literature demonstrating elevated risk in short sleepers, especially when measured by self-report. For example, several previous studies have shown that, prevalence is higher in the context of short sleep duration when hypertension is measured by self-report [1, 2, [63] [64] [65] [66] [67] and incidence also may be higher [14] . However, our findings also indicate associations between short sleep and objectively determined hypertension were largely accounted for by covariates. This finding is in contrast to several previous studies that have found that short sleep is associated with objectively-measured hypertension [68] and a recent meta-analysis demonstrating this effect across studies with short sleep (RR, 1.21 [95% confidence interval, 1.05-1.40]) [68] . This inconsistency may be due to several of the following factors: (1) the definition of objective hypertension includes current or past treatment with antihypertensive medication, which may introduce imprecision in the determination; (2) antihypertensive medications may themselves alter sleep, though this would probably be biased towards short sleep [69] ; and (3) hypertension is widely prevalent, such that a population-based sample of hypertensive subjects may represent a heterogeneous group, thus limiting precision of estimates. It is possible that these and other factors may potentially explain why laboratory studies have found inconsistent relationships between measured BP and sleep duration [68] .
Sleep duration and hyperlipidemia
Few studies have assessed associations between short sleep duration and hyperlipidemia or hypercholesterolemia. One previous study found that short sleep in adolescents was associated with high cholesterol [70] and a recent study found self-reported hypercholesterolemia in the general population to be associated with short sleep duration and self-reported insufficient sleep [2] . Alternatively, other research has found that long sleep duration was associated with high cholesterol among the elderly [71] . However, our study did find a relationship between short sleep duration and hyperlipidemia, only in the very short sleepers. This finding is consistent with a previous finding from this cohort that elevated C-reactive protein (also a risk factor for atherosclerosis) is elevated in the shortest sleep duration category, but not among less extreme short sleepers [54] .
Sleep duration and DM
The literature regarding the relationship between habitual sleep duration and DM is highly variable [3, 72, 73] . Our study found that only very short sleep was associated with elevated DM risk when measured using the standard survey question. When an objective determination was used, elevations were not found. This finding suggests that the inconsistencies in the literature are likely partially due to weak associations in the presence of confounders and measurement variability.
Sleep duration and obesity
Findings for obesity reflected the results of previously published studies [74] . Short sleep duration is associated with obesity. Interestingly, most self-reported obesity associations were significant only before including confounders into the analysis, whereas findings regarding objectively determined obesity were more consistent. This finding may be reflected in improved reliability of measurement.
Self-reported vs objective determinations
Across domains, associations generally were stronger for self-reported determinations of risk factors compared to objective determinations. In some cases, only the association with self report was significant and this pattern was reversed in obesity. This finding is in contrast to a recent meta-analysis, which found that associations between short sleep and incident hypertension were stronger if hypertension was objectively determined [68] . This analysis was cross-sectional, which may explain the difference. Perhaps self-reported sleep and self-reported health variables correlate due to other confounders, such as social desirability biases and state experiences of stress, among others. For example, a previous study found that self-reported sleep quality correlated with standard measures but tended to correlate better with depression ratings [75] . Also, the time frame of self-reports (complete history) and objective determinations, which may reflect more recent or state-dependent factors, may play a role and recall biases may differentially affect these determinations. Finally, perhaps measurement error within the non standard sleep duration item is partially responsible.
Sleep duration categories
Another pattern that emerges from our study and other recent studies (e.g., [2, 47, 48, [76] [77] [78] ) is that the phenomenon of short sleep duration as measured using population surveys represents at least two -very short sleep of <5 h, which is more strongly associated with adverse outcomes but represents only a small fraction of the population; and ''short sleep'' of 5-6 h, which accounts for the majority of short sleepers but generally is less strongly associated with adverse outcomes. This difference may be due to reporting characteristics, as the short sleep group may be more heterogeneous and may be more likely to include more individuals who are relatively unimpaired due to being a natural short sleeper who requires less sleep [17, 79] or may be more resilient to sleep loss [80] [81] [82] [83] , in addition to those who are obtaining insufficient sleep. This factor underscores the need for further research identifying and classifying subgroups of short sleepers who may be at increased (or decreased) risk for adverse outcomes.
Interactions by race/ethnicity
Few studies have addressed if the relationship between sleep duration and cardiometabolic disease depends on race. One such study found sleep duration-mediated racial differences in hypertension [49] , while other research indicated that the relationship of sleep duration to baseline C-reactive protein levels depends on race/ethnicity, with different patterns reflected throughout different groups [54] . The results of our study extend the later findings; for all outcomes except objective DM, the relationship between sleep duration and cardiometabolic disease differed by race/ethnicity. Frequently, these differences were subtle, but they may identify unique patterns of risk that would otherwise be overlooked. For example, blacks are more likely to be short sleepers in population-based studies that used subjective self-report [77, 84] , as well as regional studies that used actigraphy [85] , and our study shows that the relationship between short sleep duration and obesity is stronger in this group.
Other interesting patterns emerged in these analyses. For example, the relationship between very short sleep and self-reported hypertension was seen for all groups except Mexican-Americans and Asians/others, with the strongest effect seen among Hispanics/Latinos. Interestingly, the relationship between objective hypertension and very short sleep was only seen among other Hispanics/ Latinos. Not only does this suggest an unique relationship among non-Mexican Hispanics/Latinos, but it demonstrates the heterogeneity among Hispanics/Latinos, with no effect seen in the largest subgroup (Mexican-Americans). There currently is little known about sleep and health in the US Hispanic/Latino population [59] but other NHANES data suggest that non-Mexican Hispanics/Latinos are at increased risk for a number of sleep complaints, which are not more common among Mexican-Americans [77, 78] .
Regarding hyperlipidemia, the association with very short sleep was most evident among non-Hispanic whites and Asians/others. Other minority groups did not show an association (except that Mexican-American long sleepers had less self-reported but not objective hyperlipidemia). One previous study showed an association between very short sleep duration and hyperlipidemia in a population sample [2] , though this study also showed that the association was largely accounted for by perceived insufficiency of sleep rather than sleep duration per se. Therefore, this relationship may be partially explained by different levels of perceived insufficient sleep. In the current NHANES sample, non restorative sleep, which may be an overlapping construct with perceived sleep insufficiency, is highest among non-Hispanic whites and Asians/ others [78] .
Regarding DM, associations with very short sleep were seen most clearly among non-Hispanic whites and not other groups. This finding may explain relatively weak effects in other large population studies [1] and stronger effects in samples with more whites [86] , though this conflicts with other reports showing a stronger relationship in black Americans [11] .
It also is important to note that race/ethnicity can be recognized as a risk factor for cardiometabolic disease [87] . For example, increased obesity in racial minorities is well-described [88] , as is increased prevalence of hypertension in African-Americans [89] [90] [91] [92] and increased levels in Hispanics/Latinos of DM [93] . Immigrant status also may be an important factor in the relationship among sleep, race/ethnicity, and cardiometabolic health. Although this analysis is outside of the scope of our study, an analysis of this dataset shows that immigrants generally reported healthier sleep than US-born respondents [77, 78] . In addition, although this analysis focused on race/ethnicity, other sociodemographic factors also may be relevant. For example, previous reports have found gender differences in the relationship between sleep and cardiometabolic disease risk factors, generally with women demonstrating a stronger relationship [48, 94, 95] . In our study, women were less likely to be short or long sleepers, though they may have been more susceptible to the associated adverse health outcomes.
Potential causal pathways linking sleep duration to cardiometabolic disease
Although a full accounting of potential mechanisms linking short sleep duration and cardiometabolic disease is beyond the scope of our paper, it is important to note several possibilities. Sleep loss is associated with a proinflammatory state [96] , with noted elevations in a number of proinflammatory biomarkers such as IL-6 [97] [98] [99] [100] [101] [102] [103] and tumor necrosis factor [36, 97, 98, 100, [104] [105] [106] . Increased inflammation may be implicated in a number of cardiovascular disease processes, including development of atherosclerotic plaques and end-stage thrombotic complications [107] . Inflammation also may play a causal role in insulin sensitivity and obesity [108] . In addition, sleep loss may produce alterations in hypothalamic-pituitary-adrenal axis activity [109] [110] [111] [112] , which plays an important role linking stress and cardiovascular disease [113] . Other potential pathways may involve insulin dysregulation [33, 34, [114] [115] [116] [117] , decreased leptin (a hormone secreted by adipocytes that contributes to satiety), and increased ghrelin (a hormone secreted by the stomach to stimulate hunger) [118, 119] . Several behavioral factors also may play a role in the relationship between sleep duration and cardiometabolic disease. For example, sleep duration may be related to unhealthy dietary patterns [47, 120] , decreased physical activity [121] [122] [123] , and other health risk factors.
Study limitations
Our study is limited to a cross-sectional analysis on prevalent subclinical disease and cannot make inferences of causality. Because NHANES limits self-reports of sleep duration to integer values, which likely reflect usual habits in recent times, some misclassification bias may have occurred and would have mitigated the strength of the associations that were found in our analysis. A better approach would have been to prospectively assess sleep duration using a daily diary [124, 125] and an optimal approach also would have included concurrent actigraphy [38, 49, 126, 127] . Despite this limitation, sleep duration has been shown to correlate reasonably well with objectively measured sleep (r = 0.47) [38] .
Another limitation of the study oddly enough derives from one of its primary strengths: sample size. Although our study had a sufficient sample size at the extremes of sleep duration to detect the observed effects, individuals at these extremes represent a small portion of the population. This limitation suggests that, although these relationships are likely to exist within the population, they are most relevant for only a small subset of the general population. Our distribution of sleep duration values is consistent with that reported by other cohorts. For example, the Nurses' Health Study [128] reported 5% short sleepers and 5% long sleepers and the MrOS Study reported 8% long sleepers [44] .
Finally, while many studies have shown BMI to be an useful measure of central obesity and cardiovascular risk, BMI does not account for muscle mass, gender-or age-related differences in body fat distribution, or differences in relationships between adiposity and cardiometabolic disease among ethnoracial subgroups. Alternatives to BMI include waist-to-hip ratio, neck circumference and the index of body adiposity (hip/height 1.5-18) [129, 130] , which may better approximate central adiposity and associated cardiometabolic disease. These data were not collected for NHANES, or data regarding menopausal status, menstrual cycle phase, or use of hormone replacement therapy. Therefore, residual confounding may exist. However, this would likely attenuate the association between sleep duration and cardiometabolic disease towards the null, indicating that our findings likely represent an underestimation of the true association. Future studies also should include the addition of a social desirability scale to assess for trends in biased reporting and to further address the issues relating to a discrepancy between self-reported and objective assessments.
Conclusion
Short sleep duration and very short sleep duration in particular is associated with adverse cardiometabolic outcomes. This relationship persists with outcomes measured either objectively or through self-report and persists even after adjustment for a wide array of covariates. Long sleep duration showed less robust association with these outcomes. Further, these relationships depended on race/ethnicity. Future studies should use more precise measures of sleep duration, consider the role of sociodemographic factors, and include a longitudinal design to assess outcomes.
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